A detailed history of Trexquant Investment LP transactions in Genmab A/S stock. As of the latest transaction made, Trexquant Investment LP holds 63,847 shares of GMAB stock, worth $1.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
63,847
Previous 11,513 454.56%
Holding current value
$1.35 Million
Previous $289,000 438.41%
% of portfolio
0.02%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.84 - $28.48 $1.25 Million - $1.49 Million
52,334 Added 454.56%
63,847 $1.56 Million
Q2 2024

Aug 13, 2024

SELL
$25.13 - $30.27 $1.4 Million - $1.68 Million
-55,600 Reduced 82.85%
11,513 $289,000
Q1 2024

May 14, 2024

SELL
$26.43 - $32.77 $2.27 Million - $2.82 Million
-85,985 Reduced 56.16%
67,113 $2.01 Million
Q4 2023

Feb 09, 2024

BUY
$27.94 - $35.44 $4.28 Million - $5.43 Million
153,098 New
153,098 $4.87 Million
Q1 2023

May 15, 2023

SELL
$34.88 - $43.22 $2.66 Million - $3.3 Million
-76,312 Reduced 71.13%
30,974 $1.17 Million
Q4 2022

Feb 13, 2023

BUY
$33.8 - $47.06 $3.23 Million - $4.5 Million
95,530 Added 812.61%
107,286 $4.55 Million
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $370,549 - $4.39 Million
11,756 New
11,756 $378,000
Q2 2022

Aug 11, 2022

SELL
$26.83 - $38.57 $614,782 - $883,792
-22,914 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$30.95 - $39.68 $768,024 - $984,659
-24,815 Reduced 51.99%
22,914 $829,000
Q4 2021

Feb 14, 2022

BUY
$35.87 - $47.12 $1.71 Million - $2.25 Million
47,729 New
47,729 $1.89 Million
Q2 2021

Aug 12, 2021

SELL
$32.88 - $44.57 $225,359 - $305,482
-6,854 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$30.92 - $44.4 $211,925 - $304,317
6,854 New
6,854 $225,000
Q3 2020

Nov 06, 2020

SELL
$33.07 - $38.68 $736,601 - $861,558
-22,274 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$20.05 - $33.89 $61,172 - $103,398
3,051 Added 15.87%
22,274 $755,000
Q1 2020

May 08, 2020

BUY
$17.15 - $25.22 $329,674 - $484,804
19,223 New
19,223 $407,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.9B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.